Print

University of Maryland BioPark Announces MedImmune's Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park  
4/24/2012 8:50:03 AM

BALTIMORE, April 24, 2012 /PRNewswire/ -- The University of Maryland BioPark announced today that Bahija Jallal, Ph.D., Executive Vice President of Research and Development at MedImmune, has been appointed as the newest member of the UM Health Sciences Research Park Corporation (RPC) Board of Directors.